0001861123-22-000001.txt : 20220106 0001861123-22-000001.hdr.sgml : 20220106 20220106172127 ACCESSION NUMBER: 0001861123-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220106 DATE AS OF CHANGE: 20220106 EFFECTIVENESS DATE: 20220106 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Eikon Therapeutics, Inc. CENTRAL INDEX KEY: 0001861123 IRS NUMBER: 842807586 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-428246 FILM NUMBER: 22515643 BUSINESS ADDRESS: STREET 1: 3929 POINT EDEN WAY CITY: HAYWARD STATE: CA ZIP: 94545 BUSINESS PHONE: 415-865-2050 MAIL ADDRESS: STREET 1: 3929 POINT EDEN WAY CITY: HAYWARD STATE: CA ZIP: 94545 D 1 primary_doc.xml X0708 D LIVE 0001861123 Eikon Therapeutics, Inc. 3929 POINT EDEN WAY HAYWARD CA CALIFORNIA 94545 341-777-0566 DELAWARE None None Corporation true 2019 Roger M. Perlmutter 3929 Point Eden Way Hayward CA CALIFORNIA 94545 Executive Officer Director Dror Berman 3929 Point Eden Way Hayward CA CALIFORNIA 94545 Director Leon Chen 3929 Point Eden Way Hayward CA CALIFORNIA 94545 Director Adam Goulburn 3929 Point Eden Way Hayward CA CALIFORNIA 94545 Director Alfred Bowie 3929 Point Eden Way Hayward CA CALIFORNIA 94545 Executive Officer James Tananbaum 3929 Point Eden Way Hayward CA CALIFORNIA 94545 Director Benjamin Thorner 3929 Point Eden Way Hayward CA CALIFORNIA 94545 Executive Officer Biotechnology Decline to Disclose 06b false 2021-12-03 false true false 0 524999783 517764785 7234998 false 43 0 0 0 false Eikon Therapeutics, Inc. /s/ Roger M. Perlmutter Roger M. Perlmutter Chief Executive Officer 2022-01-06